UCSF

Valerie Clinard, PharmD

Associate Professor and Director
Department of Clinical Pharmacy
Clinard
[email protected]
Phone: +1 415 502-5494
Fax: +1 415 476-6632
533 Parnassus Ave, UC Hall, Rm 585Q
San Francisco, CA 94143
United States

Links

UCSF Profiles
Experiential Education

Educational programs

Director of Experiential Education, PharmD Degree Program

What I do

As director of experiential education, I oversee the Introductory Pharmacy Practice Experience (IPPE) and Advanced Pharmacy Practice Experience (APPE) programs. I work with preceptors, students, faculty, and staff to develop and implement new experiential education opportunities that continue to meet the needs of the expanding role of pharmacists. In addition, I work with the program directors to provide preceptor development and to ensure that preceptors, practice sites, and students benefit from the relationships and opportunities provided.

My research expertise

education research

Clinical expertise

community practice

Degrees

PGY1 Community-Based Pharmacy, Campbell University College of Pharmacy at Kerr Drug, Inc., 2001
PharmD, University of North Carolina at Chapel Hill, 2000

Research keywords

Blood Coagulation, Guidelines as Topic, pharmacy residencies, Community Pharmacy Services, International Normalized Ratio

Licensure and certifications

Licentiate in Pharmacy, North Carolina, 2000

Publications

Clinard VB, Kearney TE, Repplinger DJ, Smollin CG, Youmans SL. An interprofessional clinical toxicology advanced pharmacy practice experience. Curr Pharm Teach Learn. 2019 May; 11(5):505-512.
Thompson-Quan A, Tran JT, Clinard V. Development, Implementation, and Evaluation of Introductory Pharmacy Practice Experiences at an Academic Medical Center. J Pharm Pract. 2018 Nov 29; 897190018810046.
Ferreri SP, Brown P, Clinard VB. Developing a process for expansion of community pharmacy residency sites. J Am Pharm Assoc (2003). 2016 Nov - Dec; 56(6):660-664.
Harward JL, Clinard VB, Jiroutek MR, Lingerfeldt BH, Muzyk AJ. Impact of a US Food and Drug Administration Drug Safety Communication on Zolpidem Dosing: An Observational Retrospective Cohort. Prim Care Companion CNS Disord. 2015; 17(2).
Smith JD, Clinard VB. Natural products for the management of type 2 diabetes mellitus and comorbid conditions. J Am Pharm Assoc (2003). 2014 Sep-Oct; 54(5):e304-18; quiz e319-21.
McLendon AN, Clinard VB, Woodis CB. Ospemifene for the treatment of vulvovaginal atrophy and dyspareunia in postmenopausal women. Pharmacotherapy. 2014 Oct; 34(10):1050-60.
Kuo AM, Brown JN, Clinard V. Effect of influenza vaccination on international normalized ratio during chronic warfarin therapy. J Clin Pharm Ther. 2012 Oct; 37(5):505-9.
Smith JD, Clinard V, Barnes CL. Pharmacists' guide to infant formulas for term infants. J Am Pharm Assoc (2003). 2011 May-Jun; 51(3):e28-35; quiz e36-7.
Nye AM, Clinard VB, Barnes CL. Medication nonadherence secondary to drug-induced memory loss. Consult Pharm. 2010 Feb; 25(2):117-21.
Brock TP, Williams DM, Clinard VB, Ketcher LD. Readability of brochure about phase-out of chlorofluorocarbons in metered-dose inhalers. Am J Health Syst Pharm. 2006 May 01; 63(9):807-8.
Make a gift
We see a time when precise therapeutics—used safely and effectively—improve the health of people everywhere.
© 2002–2019 The Regents of the University of California